BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16739349)

  • 1. Prostate cancer presenting as visual changes.
    Olson KB; Pienta KJ
    Anticancer Res; 2006; 26(1B):755-8. PubMed ID: 16739349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary subdural hematoma in dural metastasis of prostatic adenocarcinoma].
    Varlet G; N'Dri Oka D; Kakou M; Echimane A; Ba Zézé V
    Rev Neurol (Paris); 2001 Dec; 157(12):1543-5. PubMed ID: 11924453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial metastatic adenocarcinoma of the prostate presenting as visual disturbance.
    Preston DM; Zeidman SM; Spevak M; Moul JW; Costabile RA
    Tech Urol; 1997; 3(1):51-3. PubMed ID: 9170227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen-positive extramammary Paget's disease--association with prostate cancer.
    Hammer A; Hager H; Steiniche T
    APMIS; 2008 Jan; 116(1):81-8. PubMed ID: 18254784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of extremely advanced prostate cancer presenting hemolytic jaundice.
    Wakisaka M; Takagishi H
    Hinyokika Kiyo; 1994 Mar; 40(3):261-3. PubMed ID: 8178748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic prostate carcinoma mimicking meningioma: case report and review of the literature.
    Lyons MK; Drazkowski JF; Wong WW; Fitch TR; Nelson KD
    Neurologist; 2006 Jan; 12(1):48-52. PubMed ID: 16547447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma.
    Kabeer MA; Lloyd-Davies E; Maskell G; Hohle R; Mathew J
    World J Surg Oncol; 2007 Jan; 5():2. PubMed ID: 17207288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Left supraclavicular adenopathy. Metastasis of carcinoma of the prostate].
    Avila Padilla J; Capell González M; Centelles Ruiz M; Ardiaca Bosch MC; Badía Torroella F; Abós Fanlo P
    Arch Esp Urol; 1993 May; 46(4):289-93. PubMed ID: 8338368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proptosis--an uncommon presentation of orbital metastases secondary to prostate cancer.
    Vissamsetti B; McArdle PA; Adams CJ; Hotiana Z; Morton AL; Alexander RJ
    Urol Int; 2007; 79(4):374-5; discussion 375. PubMed ID: 18025861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of subdural hematoma associated with dural metastasis of lung cancer].
    Ishii N; Yokosuka K; Sekihara Y; Hirano K; Suzuki Y; Ishii R
    No Shinkei Geka; 2007 May; 35(5):511-3. PubMed ID: 17491348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prostatic adenocarcinoma: a cytopathological study of 50 cases.
    Mai KT; Roustan Delatour NL; Assiri A; Al-Maghrabi H
    Diagn Cytopathol; 2007 Feb; 35(2):91-5. PubMed ID: 17230567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
    Tonita JM; Skarsgard D; Muhajarine N
    Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carcinomatous meningitis from prostate cancer diagnosed by cerebrospinal fluid cytology and magnetic resonance image: a case report and review of the literature].
    Yasufuku T; Shigemura K; Tanaka H; Matsumoto O; Nakano Y; Tanaka K; Fujisawa M
    Hinyokika Kiyo; 2009 Jun; 55(6):361-5. PubMed ID: 19588872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Small cell carcinoma of the prostate: a case report].
    Yamamoto N; Kinoshita H; Inoue T; Kawakita S; Oguchi N; Muguruma K; Kawa G; Sakaguchi Y; Adachi Y; Sakaida N; Uemura Y; Matsuda T
    Hinyokika Kiyo; 2007 Sep; 53(9):665-9. PubMed ID: 17933147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.
    Goya M; Ishii G; Miyamoto S; Hasebe T; Nagai K; Yonou H; Hatano T; Ogawa Y; Ochiai A
    Prostate; 2006 Nov; 66(15):1573-84. PubMed ID: 16927388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.